Test ID: FPTHC
PTH Accuratio Comprehensive Profile
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
COMPREHENSIVE PROFILE
TOTAL PTH Reference Range: 14.0-66.0 pg/mL
CAP PTH Reference Range: 5.0-39.0 pg/mL
CIP VALUE Reference Range: 2.5-29.0 pg/mL
CAP/CIP Reference Range: 1.1-6.9 ratio
Low ratio or PTH values are associated with Adynamic bone turnover
status for an ESRD patient.
Total PTH:
Total Intact PTH is the sum of CAP PTH and N-truncated PTH
fragment (likely 7-84) Total PTH = Intact PTH = CAP + CIP.
FDA approved.
CAP PTH:
CAP stands for Cyclase Activating PTH and is the same as
Whole PTH which is 1-84 PTH and which raises bone turnover.
FDA approved.
CIP VALUE:
CIP stands for Cyclase Inactive PTH and the N-truncated PTH
fragment, likely 7-84 PTH. CIP = Total PTH – CAP.
CAP/CIP:
CAP/CIP ratio is a calculated value and has been shown to be
93% predictive of bone turnover for the ESRD patient, however,
bone biopsy is 100% predictive, therefore, clinical correlation
is recommended.
Reference ranges were established using a 95% reference
interval on a normal population with normal functioning kidneys.
These reference ranges should not be applied to ESRD
patients with impaired or non-functioning renal function.
TEST PERFORMED BY:
SCANTIBODIES CLINICAL LABORATORY, INC.
9236 ABRAHAM WAY
SANTEE, CA 92701
Clinical Reference
Provides recommendations for further in-depth reading of a clinical nature
REFERENCES:
CAP reference range 90-170 pgm/mL & Ratio <1.4 = Adynamic
Bone Disease
Tokumoto, A J Amer Soc Nephrol 2003 (Nov); 14:702
Tokumoto, A J Amer Soc Nephrol 2003 (Nov); 14:700
CAP/CIP Ratio 93% predictive:
Faugere M-C, Geng Z, Mawad H, Friedler RM, Gao P,
Cantor T, Malluche H. Kidney Int 2001; 60: 1460-1468.
Total PTH>1000 pg/mL & RATIO <or=1.4=High Bone Turnover
American Journal of Kidney Diseases, Vol 26, No4 (Oct),
1995: pp622-31
TEST PERFORMED BY:
SCANTIBODIES CLINICAL LABORATORY, INC.
9236 ABRAHAM WAY
SANTEE, CA 92701


